Home » Topics » Disease categories and therapies » Infection

Infection
RSS

BioCryst licenses small-molecule neuraminidase inhibitors to J&J companies

Sep. 16, 1998

Wyeth-Lederle researchers discover potential treatment for RSV infection

Sep. 15, 1998

Siga identifies lead antibiotic compound

Sep. 11, 1998

U.S. university researchers discover nucleoside analogues for EBV

Sep. 9, 1998

Broad-spectrum antiviral agents in development at Pfizer

Sep. 8, 1998

Nymox discovers new treatment for E. coli 0157:H7 infection

Sep. 8, 1998

New antibacterial/antitumor agents produced by fungal strains discovered by Kyowa Hakko

Sep. 8, 1998

Broad-spectrum parenteral cephalosporin launched this week in Japan

Sep. 7, 1998

Maracenines: isolation and characterization of new antibacterial agents

Sep. 7, 1998

Antimicrobial polypeptides claimed by Fujisawa for infectious diseases

Sep. 4, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 17, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 17, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.